Ra Capital Management Portfolio
ActivistRA CAPITAL MANAGEMENT, L.P. 13F holdings · Q3 2026 vs Q2 2026
Why activist: 83 holdings, 13 effective · top 10 60% · turnover 44% a quarter · earnings yield -11.6% (median 2.9%) · 57 Schedule 13D filings, 27% of the book · 23 quarters of 13Fs
- 13F value
- $10.0bn−13.4% vs $11.5bn in Q2 2026
- Holdings
- 81 17 new · 9 sold out
- Top 10 weight
- 39.5% Largest: PBLS 9.5%
- Bought est.
- $958m New positions and adds
- Sold est.
- $676m Trims and exits
- Quarter
- Q3 2026 Filed
Largest trades since Q2 2026
Estimated dollars: the change in shares times the quarter-end price the filing implies. Exits use last quarter's value.
| Action | Stock | Shares | Est. traded | Weight | Other gurus |
|---|---|---|---|---|---|
| New | FRNMFREENOME INC | New | +$242m | 0.0% → 2.4% | 4 |
| Sold out | BCRXBIOCRYST PHARMACEUTICALS INC | −100.0% | −$158m | 1.4% → 0.0% | — |
| New | AMLXAMYLYX PHARMACEUTICALS INC | New | +$125m | 0.0% → 1.2% | 2 |
| New | WVEWAVE LIFE SCIENCES INC | New | +$100m | 0.0% → 1.0% | 1 |
| New | LTGOLATIGO BIOTHERAPEUTICS INC | New | +$89m | 0.0% → 0.9% | 2 |
| New | OBXOBSIDIAN THERAPEUTICS INC | New | +$82m | 0.0% → 0.8% | 4 |
| Trimmed | ZLABZAI LAB LTD-ADR | −51.0% | −$77m | 0.9% → 0.7% | 4 |
| Sold out | NTLAINTELLIA THERAPEUTICS INC | −100.0% | −$77m | 0.7% → 0.0% | — |
| Sold out | DFTXDEFINIUM THERAPEUTICS INC | −100.0% | −$71m | 0.6% → 0.0% | — |
| Trimmed | SEPNSEPTERNA INC | −21.3% | −$58m | 2.0% → 2.2% | 2 |
| New | DBVTDBV TECHNOLOGIES SA-SPON ADR | New | +$43m | 0.0% → 0.4% | 2 |
| Sold out | AKTSAKTIS ONCOLOGY INC | −100.0% | −$42m | 0.4% → 0.0% | — |
| Sold out | BIOABIOAGE LABS INC | −100.0% | −$41m | 0.4% → 0.0% | — |
| New | AGENAGENUS INC | New | +$41m | 0.0% → 0.4% | 1 |
| Added | VORVOR BIOPHARMA INC | +87.5% | +$40m | 0.4% → 0.9% | 4 |
| Added | TSHATAYSHA GENE THERAPIES INC | +29.2% | +$34m | 1.4% → 1.5% | 5 |
| New | SCTXSCRIBE THERAPEUTICS INC | New | +$33m | 0.0% → 0.3% | 4 |
| New | KRSAKORSANA BIOSCIENCES INC | New | +$29m | 0.0% → 0.3% | 5 |
| Trimmed | JBIOJADE BIOSCIENCES INC | −50.0% | −$26m | 0.7% → 0.3% | 3 |
| New | ETRAELECTRA THERAPEUTICS INC | New | +$19m | 0.0% → 0.2% | 2 |
| Sold out | KPTIQKARYOPHARM THERAPEUTICS INC | −100.0% | −$19m | 0.2% → 0.0% | — |
| Trimmed | SIONSIONNA THERAPEUTICS INC | −34.8% | −$18m | 3.8% → 0.3% | 1 |
| New | SGMTSAGIMET BIOSCIENCES INC-A | New | +$18m | 0.0% → 0.2% | 3 |
| Trimmed | FTHFAETH THERAPEUTICS INC | −71.6% | −$15m | 0.2% → 0.1% | 4 |
| New | IKTINHIBIKASE THERAPEUTICS INC | New | +$14m | 0.0% → 0.1% | 1 |
| Trimmed | MIRMMIRUM PHARMACEUTICALS INC | −50.0% | −$14m | 0.3% → 0.1% | 8 |
| Trimmed | CLYMCLIMB BIO INC | −10.4% | −$13m | 1.3% → 1.2% | 0 |
| New | CRBPCORBUS PHARMACEUTICALS HOLDI | New | +$13m | 0.0% → 0.1% | 2 |
| Trimmed | OVIDOVID THERAPEUTICS INC | −46.7% | −$12m | 0.2% → 0.1% | 0 |
| New | BRVEBRAVEHEART BIO INC | New | +$11m | 0.0% → 0.1% | 4 |
| Sold out | WAYWAYSTAR HOLDING CORP | −100.0% | −$11m | 0.1% → 0.0% | — |
| Trimmed | ABVXABIVAX SA-ADR | −9.1% | −$10m | 1.3% → 1.0% | 6 |
| New | INOINOVIO PHARMACEUTICALS INC | New | +$8.8m | 0.0% → 0.1% | 0 |
| Added | PBLSPARABILIS MEDICINES INC | +0.8% | +$7.9m | 6.9% → 9.5% | 5 |
| Sold out | CRVSCORVUS PHARMACEUTICALS INC | −100.0% | −$6.7m | 0.1% → 0.0% | — |
| Trimmed | AVRANTERIS TECHNOLOGIES GLOBAL | −17.5% | −$4.1m | 0.3% → 0.2% | 4 |
| Added | ARTVARTIVA BIOTHERAPEUTICS INC | +3.0% | +$3.8m | 1.5% → 1.3% | 0 |
| New | STROSUTRO BIOPHARMA INC | New | +$3.4m | 0.0% → 0.0% | 3 |
| New | STOKSTOKE THERAPEUTICS INC | New | +$1.9m | 0.0% → 0.0% | 4 |
| Trimmed | EQEQUILLIUM INC | −25.1% | −$1.3m | 0.1% → 0.0% | 1 |
| Sold out | HOWLWEREWOLF THERAPEUTICS INC | −100.0% | −$859k | 0.0% → 0.0% | — |
| Added | CCCCC4 THERAPEUTICS INC | +2.4% | +$649k | 0.3% → 0.3% | 2 |
| Trimmed | GERNGERON CORP | −0.1% | −$68k | 0.5% → 0.5% | 2 |
| Trimmed | CAPRCAPRICOR THERAPEUTICS INC | 0.0% | −$14k | 0.3% → 0.3% | 3 |
All holdings 81 identified, plus $2.8bn in securities without a listed ticker
Click a column to sort. Values are as reported at quarter-end, not today's prices.
| # | Stock | Shares | ||||
|---|---|---|---|---|---|---|
| 1 | PBLSPARABILIS MEDICINES INC | $942m | 29,177,964 | +0.8% | 5 | |
| 2 | PCVXVAXCYTE INC | $653m | 11,474,599 | Unchanged | 3 | |
| 3 | RYTMRHYTHM PHARMACEUTICALS INC | $635m | 6,666,837 | Unchanged | 3 | |
| 4 | EWTXEDGEWISE THERAPEUTICS INC | $341m | 8,392,730 | Unchanged | 4 | |
| 5 | TYRATYRA BIOSCIENCES INC | $267m | 12,198,625 | Unchanged | 5 | |
| 6 | FRNMFREENOME INC | $242m | 15,367,270 | New | 4 | |
| 7 | COAGHEMAB THERAPEUTICS HOLDINGS | $241m | 7,808,627 | Unchanged | 4 | |
| 8 | SEPNSEPTERNA INC | $215m | 5,502,858 | −21.3% | 2 | |
| 9 | SGPSPYGLASS PHARMA INC | $209m | 8,021,117 | Unchanged | — | |
| 10 | JANXJANUX THERAPEUTICS INC | $193m | 11,189,693 | Unchanged | 2 | |
| 11 | MLYSMINERALYS THERAPEUTICS INC | $193m | 7,692,750 | Unchanged | 3 | |
| 12 | IRONDISC MEDICINE INC | $160m | 2,450,221 | Unchanged | 6 | |
| 13 | TSHATAYSHA GENE THERAPIES INC | $148m | 30,435,190 | +29.2% | 5 | |
| 14 | BCAXBICARA THERAPEUTICS INC | $135m | 7,255,993 | Unchanged | 1 | |
| 15 | ARTVARTIVA BIOTHERAPEUTICS INC | $132m | 18,489,293 | +3.0% | — | |
| 16 | XNCRXENCOR INC | $132m | 5,274,274 | Unchanged | 4 | |
| 17 | ORKAORUKA THERAPEUTICS INC | $129m | 1,554,597 | Unchanged | 5 | |
| 18 | AMLXAMYLYX PHARMACEUTICALS INC | $125m | 4,279,341 | New | 2 | |
| 19 | CLYMCLIMB BIO INC | $116m | 10,130,130 | −10.4% | — | |
| 20 | ABVXABIVAX SA-ADR | $102m | 1,030,058 | −9.1% | 6 | |
| 21 | WVEWAVE LIFE SCIENCES INC | $100m | 26,975,505 | New | 1 | |
| 22 | LTGOLATIGO BIOTHERAPEUTICS INC | $89m | 5,302,933 | New | 2 | |
| 23 | SLDBSOLID BIOSCIENCES INC | $87m | 12,036,126 | Unchanged | 2 | |
| 24 | VORVOR BIOPHARMA INC | $86m | 4,503,882 | +87.5% | 4 | |
| 25 | LBRXLB PHARMACEUTICALS INC | $85m | 2,208,604 | Unchanged | 3 | |
| 26 | OBXOBSIDIAN THERAPEUTICS INC | $82m | 5,957,103 | New | 4 | |
| 27 | ZLABZAI LAB LTD-ADR | $74m | 2,815,543 | −51.0% | 4 | |
| 28 | FDMT4D MOLECULAR THERAPEUTICS IN | $72m | 5,049,779 | Unchanged | 3 | |
| 29 | ACRSACLARIS THERAPEUTICS INC | $67m | 12,723,026 | Unchanged | 2 | |
| 30 | SANASANA BIOTECHNOLOGY INC | $55m | 18,750,000 | Unchanged | 1 | |
| 31 | MNPRMONOPAR THERAPEUTICS INC | $53m | 667,207 | Unchanged | 2 | |
| 32 | GERNGERON CORP | $53m | 42,754,145 | −0.1% | 2 | |
| 33 | PEPGPEPGEN INC | $49m | 20,064,545 | Unchanged | — | |
| 34 | SPRYARS PHARMACEUTICALS INC | $47m | 10,860,977 | Unchanged | 3 | |
| 35 | ABOSACUMEN PHARMACEUTICALS INC | $47m | 20,992,669 | Unchanged | — | |
| 36 | DBVTDBV TECHNOLOGIES SA-SPON ADR | $43m | 3,657,644 | New | 2 | |
| 37 | AGENAGENUS INC | $41m | 4,122,000 | New | 1 | |
| 38 | RZLTREZOLUTE INC | $39m | 9,445,039 | Unchanged | — | |
| 39 | SIONSIONNA THERAPEUTICS INC | $34m | 6,456,234 | −34.8% | 1 | |
| 40 | SCTXSCRIBE THERAPEUTICS INC | $33m | 1,802,178 | New | 4 | |
| 41 | IPSCCENTURY THERAPEUTICS INC | $30m | 17,754,430 | Unchanged | 2 | |
| 42 | EVMNEVOMMUNE INC | $29m | 3,494,638 | Unchanged | 3 | |
| 43 | KRSAKORSANA BIOSCIENCES INC | $29m | 892,743 | New | 5 | |
| 44 | CAPRCAPRICOR THERAPEUTICS INC | $29m | 3,014,183 | 0.0% | 3 | |
| 45 | NKTXNKARTA INC | $28m | 10,805,129 | Unchanged | — | |
| 46 | CCCCC4 THERAPEUTICS INC | $27m | 8,194,779 | +2.4% | 2 | |
| 47 | JBIOJADE BIOSCIENCES INC | $26m | 1,835,542 | −50.0% | 3 | |
| 48 | PRLDPRELUDE THERAPEUTICS INC | $25m | 6,475,882 | Unchanged | 1 | |
| 49 | ACRVACRIVON THERAPEUTICS INC | $25m | 12,229,396 | Unchanged | — | |
| 50 | ASMBASSEMBLY BIOSCIENCES INC | $24m | 1,020,410 | Unchanged | 2 | |
| 51 | EDITEDITAS MEDICINE INC | $23m | 8,889,000 | Unchanged | 2 | |
| 52 | QTTBQ32 BIO INC | $19m | 2,332,457 | Unchanged | 3 | |
| 53 | AVRANTERIS TECHNOLOGIES GLOBAL | $19m | 2,474,076 | −17.5% | 4 | |
| 54 | ETRAELECTRA THERAPEUTICS INC | $19m | 1,692,965 | New | 2 | |
| 55 | ALTALTIMMUNE INC | $19m | 6,500,000 | Unchanged | — | |
| 56 | BNTCBENITEC BIOPHARMA INC | $19m | 1,850,000 | Unchanged | 2 | |
| 57 | ALXOALX ONCOLOGY HOLDINGS INC | $18m | 13,011,849 | Unchanged | 1 | |
| 58 | SGMTSAGIMET BIOSCIENCES INC-A | $18m | 1,800,000 | New | 3 | |
| 59 | LXEOLEXEO THERAPEUTICS INC | $17m | 5,000,000 | Unchanged | 4 | |
| 60 | LENZLENZ THERAPEUTICS INC | $16m | 4,178,823 | Unchanged | 1 | |
| 61 | AURAAURA BIOSCIENCES INC | $16m | 2,500,000 | Unchanged | 3 | |
| 62 | AVTXAVALO THERAPEUTICS INC | $15m | 1,000,000 | Unchanged | 5 | |
| 63 | IKTINHIBIKASE THERAPEUTICS INC | $14m | 6,970,000 | New | 1 | |
| 64 | SPTXSEAPORT THERAPEUTICS INC | $14m | 700,000 | Unchanged | 2 | |
| 65 | SABSSAB BIOTHERAPEUTICS INC | $14m | 4,401,500 | Unchanged | 2 | |
| 66 | OVIDOVID THERAPEUTICS INC | $14m | 5,598,200 | −46.7% | — | |
| 67 | MIRMMIRUM PHARMACEUTICALS INC | $14m | 159,278 | −50.0% | 8 | |
| 68 | DRUGBRIGHT MINDS BIOSCIENCES INC | $13m | 265,000 | Unchanged | 1 | |
| 69 | CRBPCORBUS PHARMACEUTICALS HOLDI | $13m | 1,914,788 | New | 2 | |
| 70 | BRVEBRAVEHEART BIO INC | $11m | 565,000 | New | 4 | |
| 71 | OKURONKURE THERAPEUTICS INC-A | $11m | 3,998,333 | Unchanged | 2 | |
| 72 | PALIPALISADE BIO INC | $9.6m | 7,124,116 | Unchanged | 2 | |
| 73 | INOINOVIO PHARMACEUTICALS INC | $8.8m | 7,220,384 | New | — | |
| 74 | MGNXMACROGENICS INC | $7.2m | 1,864,176 | Unchanged | 1 | |
| 75 | RANIRANI THERAPEUTICS HOLDINGS-A | $6.7m | 8,500,000 | Unchanged | 1 | |
| 76 | ACETADICET BIO INC | $6.7m | 932,624 | Unchanged | — | |
| 77 | FTHFAETH THERAPEUTICS INC | $6.1m | 205,060 | −71.6% | 4 | |
| 78 | EQEQUILLIUM INC | $3.8m | 2,317,741 | −25.1% | 1 | |
| 79 | STROSUTRO BIOPHARMA INC | $3.4m | 210,934 | New | 3 | |
| 80 | STOKSTOKE THERAPEUTICS INC | $1.9m | 73,607 | New | 4 | |
| 81 | PTNPALATIN TECHNOLOGIES INC | $551k | 62,124 | Unchanged | — |
Closest portfolios
Overlap is the weight two books have in common: for each shared stock, the smaller of the two weights, summed.
- Perceptive Advisors15.6%19 shared · RYTM, EWTX, FRNM, ORKA
- TCG Crossover Management13.5%19 shared · TYRA, IRON, XNCR, AMLX
- Paradigm Biocapital Advisors11.2%11 shared · EWTX, PCVX, TYRA, ORKA
- Novo Holdings10.2%6 shared · EWTX, PCVX, COAG, OBX
- Bvf6.2%12 shared · TYRA, XNCR, FDMT, IRON
- Frazier Life Sciences Management6.2%9 shared · PBLS, IRON, VOR, ZLAB
- Rtw Investments5.3%16 shared · XNCR, ORKA, ZLAB, TSHA
- Baker Bros. Advisors4.5%20 shared · RYTM, EWTX, PRLD, MIRM
- Deerfield Management4.4%11 shared · MLYS, PBLS, IRON, SPRY
- Avoro Capital Advisors3.5%9 shared · TSHA, COAG, SEPN, ABVX
Only here
The largest holdings no other tracked guru owns.
- SGPSPYGLASS PHARMA INC2.1%
- ARTVARTIVA BIOTHERAPEUTICS INC1.3%
- CLYMCLIMB BIO INC1.2%
- PEPGPEPGEN INC0.5%
- ABOSACUMEN PHARMACEUTICALS INC0.5%
- RZLTREZOLUTE INC0.4%
- NKTXNKARTA INC0.3%
- ACRVACRIVON THERAPEUTICS INC0.3%
- ALTALTIMMUNE INC0.2%
- OVIDOVID THERAPEUTICS INC0.1%
- INOINOVIO PHARMACEUTICALS INC0.1%
- ACETADICET BIO INC0.1%
A 13F is a filing, not a live portfolio. It lists US-listed long stock positions at quarter-end, and it arrives up to 45 days later. Cash, shorts, bonds, options and foreign listings are not in it. Trade sizes here are estimates from the change in share count, restated for stock splits.
Snapshot refreshed